The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors
Abstract
In a previous study, it was found that both the benzodiazepine hypnotic, midazolam, and the imidazopyridine hypnotic, zolpidem, which has selective affinity for a sub-population of omega (benzodiazepine, BZ) modulatory sites of GABA(A) receptors, produced similar decreases in rates of food-reinforced lever pressing in rats. However, during 10 days of repeated administration, marked tolerance developed to the depressant effect of midazolam but little tolerance developed with zolpidem. It was found in the present study that, with a within-subject design similar to that used previously, tolerance developed to the response rate-decreasing activity of the benzodiazepine, triazolam and the cyclopyrrolone, zopiclone but not to that of the triazolopyridazine, CL 218,872. In another experiment, using a between-groups design, tolerance developed to the effect of midazolam, even if the injections were not associated with daily test sessions, providing no evidence for a drug-environment interaction. The lack of tolerance to zolpidem was confirmed in two experiments. There was little indication of tolerance to the depressant effect of zolpidem, even after 19 days administration of daily doses, up to 30 mg/kg, a dose 10 times greater than that which completely suppressed responding. These results showed that the extent to which tolerance develops to the effects of drugs with affinity for omega (BZ) modulatory sites can show wide variations which may be related to differences in mechanisms of action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“supported by studies in which chronic treatment with zolpidem (but not midazolam) did not produce any tolerance to sedative and anticonvulsant effects in mice and rats [160–162].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [160]
Citations
Cites
γ‐Aminobutyric AcidA Receptor α5‐Subunit Creates Novel Type II Benzodiazepine Receptor Pharmacology
Pritchett, D. B., & Seeburg, P. H. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01237.x · Cited by 503
Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors
Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Klepner, C. A., Myers, V., & Beer, B. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90341-1 · Cited by 408
Lippa, A. S., Coupet, J., Greenblatt, E. N., Klepner, C. A., & Beer, B. (1979) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(79)90304-6 · Cited by 283
Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
Depoortere, H., Zivkovic, B., Lloyd, K. G., Sanger, D. J., Perrault, G., Langer, S. Z., & Bartholini, G. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24899-6 · Cited by 282
Self-citationMargules, D. L., & Stein, L. (1968) · Psychopharmacologia · doi:10.1007/bf00401620 · Cited by 227
Tolerance to the behavioral actions of benzodiazepines
File, S. E. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90037-5 · Cited by 205
Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats
File, S. E. (1981) · Psychopharmacology · doi:10.1007/bf00422410 · Cited by 117
Bénavidès, J., Peny, B., Dubois, A., Perrault, G., Morel, E., Živković, B., & Scatton, B. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24071-x · Cited by 93
The Role of Instrumental Learning in Behavioral Tolerance to Drugs
Wolgin, D. L. (1989) · Humana Press eBooks · doi:10.1007/978-1-59259-464-1_2 · Cited by 82
Langer, S. Z., & Arbilla, S. (1988) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1988.tb00629.x · Cited by 77
Cited by
Behavioral Pharmacology of Zolpidem Relative to Benzodiazepines A Review
Rush, C. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00102-6 · Cited by 260
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
Sanger, D. J., Benavides, J., Perrault, G., Morel, E., Cohen, C., Joly, D., & Zivkovic, B. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90049-3 · Cited by 161
Self-citationBeyond Benzodiazepines: Alternative Pharmacologic Agents for the Treatment of Insomnia
Wagner, J., Wagner, M. L., & Hening, W. A. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17111 · Cited by 161
The safety and tolerability of zolpidem — an update
DARCOURT, G., Pringuey, D., Sallière, D., & Lavoisy, J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300109 · Cited by 139
Metadata
- Authors
- Sanger, D.
- Corresponding author
- Sanger, D
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 1992-07
- Volume
- 31
- Issue
- 7
- Pages
- 693-700
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2060088347
- Cited by
- 44
- References
- 25
- Citations by year
- 2014: 2 · 2012: 2
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- benzodiazepine tolerance, GABAA receptor, midazolam, zolpidem, zopiclone, triazolam, CL 218,872, hypnotics, benzodiazepine receptor agonists
- MeSH terms
- Zolpidem, Animals, Binding Sites, Conditioning, Operant, Dose-Response Relationship, Drug, Drug Tolerance, Male, Midazolam, Piperazines, Pyridines, Receptors, GABA-A, Reinforcement, Psychology, Anti-Anxiety Agents, Triazolam, Rats, Wistar, Rats, Azabicyclo Compounds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors. https://app.cochat.ai/papers/10.1016/0028-3908(92)90148-i
- The paper
- Sanger, D. (1992). Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the omega (BZ) modulatory sites of GABAA receptors. Neuropharmacology. https://doi.org/10.1016/0028-3908(92)90148-i
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.